Senti Biosciences Financials - Benzinga

Senti Biosciences Holdings Inc

SNTINASDAQ

Trade with Public

Trade with Public

$0.3430

0.0051.48%

가까이에: Sep 24, 5:00 PM EST

$0.3100

-0.033-9.62%

시간외: 7:59 PM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 주식 보고서

Senti Biosciences Financials

Senti Biosciences (SNTI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from

Benzinga Newsdesk

PRO
Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 11.11 percent. This is a 20.9 percent increase over losses of $(0.67) per share

Benzinga Newsdesk

PRO
Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share

Benzinga Newsdesk

PRO
Senti Biosciences Q2 EPS $(0.56) Beats $(0.90) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.78 percent. This is a 77.14 percent increase over losses of $(2.45) per share from

Benzinga Newsdesk

PRO
Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY

Benzinga Newsdesk

PRO
Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved